Eli Lilly and Company
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $8.82B | $3.76B | $5.06B | $646.0M |
| FY2025 | $16.81B | $8.97B | $7.84B | $626.0M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $8.82B | $3.76B | $5.06B | $646.0M |
| FY2025 | $16.81B | $8.97B | $7.84B | $626.0M |